Analysis on Application and Funding Situation of General，Young Scholar and Regional Scholar Programs from NSFC in Field of Integrated Traditional Chinese and Western Medicine in 2023
10.13422/j.cnki.syfjx.20232447
- VernacularTitle:2023年国家自然科学基金中西医结合学科面青地项目申请与资助情况分析
- Author:
Yuan XU
1
;
Zipeng GONG
1
;
Juan LI
1
;
Jinwei ZHANG
1
;
Xuewei LIU
1
Author Information
1. Department of Health Sciences，National Natural Science Foundation of China，Beijing 100085，China
- Publication Type:Journal Article
- Keywords:
National Natural Science Foundation of China（NSFC）;
integrated traditional Chinese and western medicine;
funded projects in 2023;
research hotspots;
general programs;
young scholar programs;
regional scholar programs
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2024;30(2):172-178
- CountryChina
- Language:Chinese
-
Abstract:
By combing the application and funding situation of general， young scholar and regional scholar programs from National Natural Science Foundation of China（NSFC） in field of integrated traditional Chinese and western medicine in 2023， this paper summarizes the distribution of supporting units， application and funding hotspots， and the problems of application and funding projects in this discipline， in order to provide a reference for applicants and supporting organizations to understand the hotspot dynamics and reporting requirements of the discipline. In 2023， the discipline of integrated traditional Chinese and western medicine received a total of 2 793 applications， and there were 1 254 applications for general programs， 1 278 applications for young scholar programs， and 261 applications for regional scholar programs. The amounts of project funding obtained by the three were 145， 164 and 35， respectively， and the funding rates were 11.56%， 12.83% and 13.41% in that order. From the situation of obtaining funding， the age distribution of the project leaders who obtained funding for the general， young scholar and regional scholar programs were mainly distributed in the age of 40-46， 30-34， 38-44 years， respectively. Within the supported programs， the Chinese medicine affiliations accounted for 55.52%. With respect to research subjects， the proportion of one single Chinese herbs， or monomers， or extracts accounted for 29.4%， but the proportion of Chinese herb pairs or prescriptions accounted for 47.1%. Research hotspots included ferroptosis， bile acid metabolism， macrophages， mitochondria， microglia， exosomes， intestinal flora， microecology and so on. The current research mainly focused on the common key problems of the advantageous diseases of Chinese and western integrative medicine， but still need to be improved in the basic theories of Chinese and western medicine and multidisciplinary cross-disciplinary research.
